Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Current Leases (2022 - 2023)

Cullinan Therapeutics (CGEM) has 2 years of Current Leases data on record, last reported at $1.5 million in Q3 2023.

  • For Q3 2023, Current Leases rose 122.27% year-over-year to $1.5 million; the TTM value through Sep 2023 reached $1.5 million, up 122.27%, while the annual FY2022 figure was $1.4 million, N/A changed from the prior year.
  • Current Leases reached $1.5 million in Q3 2023 per CGEM's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.7 million in Q2 2023 and bottomed at $519000.0 in Q1 2022.